ARTICLE | Distillery Therapeutics
Therapeutics: Lysophosphatidic acid receptor 2 (LPAR2; EDG4; LPA2)
March 5, 2015 8:00 AM UTC
In vitro and mouse studies suggest that an LPAR2 agonist could help treat radiation-induced gastrointestinal syndrome. A chemical screen identified a sulfamoyl benzoic acid analog that agonized LPAR2 ...